Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging and research.
The global Microbubbles & Ultrasound Contrast Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Rising research for the use of microbubbles as an effective media for drug delivery and gene therapy, and related positive outcomes are expected to provide significant opportunities in this market. However, complexity in contrast enhanced ultrasound (CEUS) procedures, lack of training and financial resources, and side effects related to ultrasound contrast agents hinder the growth of the market to some extent.
This report aims to provide a comprehensive presentation of the global market for Microbubbles & Ultrasound Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbubbles & Ultrasound Contrast Agents.
Report Scope
The Microbubbles & Ultrasound Contrast Agents market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbubbles & Ultrasound Contrast Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbubbles & Ultrasound Contrast Agents companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Lantheus Holdings
Bracco
GE Healthcare
Daiichi Sankyo
NanoPET Pharma
Segment by Type
Power Ultrasound
Detection of Ultrasonic
Segment by Application
Military
Medical
Industrial
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbubbles & Ultrasound Contrast Agents companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Power Ultrasound
1.2.3 Detection of Ultrasonic
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Military
1.3.3 Medical
1.3.4 Industrial
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Microbubbles & Ultrasound Contrast Agents Growth Trends by Region
2.2.1 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microbubbles & Ultrasound Contrast Agents Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Microbubbles & Ultrasound Contrast Agents Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Dynamics
2.3.1 Microbubbles & Ultrasound Contrast Agents Industry Trends
2.3.2 Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Drivers
2.3.3 Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Challenges
2.3.4 Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbubbles & Ultrasound Contrast Agents Players by Revenue
3.1.1 Global Top Microbubbles & Ultrasound Contrast Agents Players by Revenue (2019-2024)
3.1.2 Global Microbubbles & Ultrasound Contrast Agents Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Microbubbles & Ultrasound Contrast Agents Revenue
3.4 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbubbles & Ultrasound Contrast Agents Revenue in 2023
3.5 Microbubbles & Ultrasound Contrast Agents Key Players Head office and Area Served
3.6 Key Players Microbubbles & Ultrasound Contrast Agents Product Solution and Service
3.7 Date of Enter into Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbubbles & Ultrasound Contrast Agents Breakdown Data by Type
4.1 Global Microbubbles & Ultrasound Contrast Agents Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Microbubbles & Ultrasound Contrast Agents Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Microbubbles & Ultrasound Contrast Agents Breakdown Data by Application
5.1 Global Microbubbles & Ultrasound Contrast Agents Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Microbubbles & Ultrasound Contrast Agents Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Microbubbles & Ultrasound Contrast Agents Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lantheus Holdings
11.1.1 Lantheus Holdings Company Detail
11.1.2 Lantheus Holdings Business Overview
11.1.3 Lantheus Holdings Microbubbles & Ultrasound Contrast Agents Introduction
11.1.4 Lantheus Holdings Revenue in Microbubbles & Ultrasound Contrast Agents Business (2019-2024)
11.1.5 Lantheus Holdings Recent Development
11.2 Bracco
11.2.1 Bracco Company Detail
11.2.2 Bracco Business Overview
11.2.3 Bracco Microbubbles & Ultrasound Contrast Agents Introduction
11.2.4 Bracco Revenue in Microbubbles & Ultrasound Contrast Agents Business (2019-2024)
11.2.5 Bracco Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Microbubbles & Ultrasound Contrast Agents Introduction
11.3.4 GE Healthcare Revenue in Microbubbles & Ultrasound Contrast Agents Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Detail
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Microbubbles & Ultrasound Contrast Agents Introduction
11.4.4 Daiichi Sankyo Revenue in Microbubbles & Ultrasound Contrast Agents Business (2019-2024)
11.4.5 Daiichi Sankyo Recent Development
11.5 NanoPET Pharma
11.5.1 NanoPET Pharma Company Detail
11.5.2 NanoPET Pharma Business Overview
11.5.3 NanoPET Pharma Microbubbles & Ultrasound Contrast Agents Introduction
11.5.4 NanoPET Pharma Revenue in Microbubbles & Ultrasound Contrast Agents Business (2019-2024)
11.5.5 NanoPET Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Lantheus Holdings
Bracco
GE Healthcare
Daiichi Sankyo
NanoPET Pharma
Ìý
Ìý
*If Applicable.